Xvivo Perfusion AB (publ) (STO:XVIVO)

Sweden flag Sweden · Delayed Price · Currency is SEK
326.50
-4.50 (-1.36%)
Mar 26, 2025, 5:29 PM CET
Market Cap 10.28B
Revenue (ttm) 822.42M
Net Income (ttm) 172.18M
Shares Out 31.50M
EPS (ttm) 5.44
PE Ratio 60.02
Forward PE 66.06
Dividend n/a
Ex-Dividend Date n/a
Volume 125,123
Average Volume 116,328
Open 340.00
Previous Close 331.00
Day's Range 324.00 - 344.50
52-Week Range 261.50 - 547.00
Beta 2.10
RSI 22.44
Earnings Date Apr 24, 2025

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden, the United States, the Netherlands, Italy, North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a c... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1998
Employees 170
Stock Exchange Nasdaq Stockholm
Ticker Symbol XVIVO
Full Company Profile

Financial Performance

In 2024, Xvivo Perfusion AB's revenue was 822.42 million, an increase of 37.63% compared to the previous year's 597.54 million. Earnings were 172.18 million, an increase of 87.52%.

Financial Statements

News

There is no news available yet.